2021
DOI: 10.1097/mog.0000000000000789
|View full text |Cite
|
Sign up to set email alerts
|

Role of gut–kidney axis in renal diseases and IgA nephropathy

Abstract: Purpose of review Growing evidence show the importance of gut/kidney axis in renal diseases. Advances in gut microbiome sequencing, associated metabolites, detection of gut permeability and inflammation provide new therapeutic strategies targeting gut for kidney diseases and particularly for Immunoglobulin A (IgA) nephropathy (IgAN). Recent findings The diversity and composition of gut flora have been recently deeply explored in kidney diseases. Modulat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 83 publications
0
17
0
Order By: Relevance
“…Intestinal inflammation with associated increased intestinal permeability and modifications to the gut microbiota, are shared pathogenic features between these two conditions. 83 Furthermore, it is unclear whether IgAN associated to IBD van be considered a primary form of IgAN as opposed to secondary IgAN as seen in liver disorders, neoplastic, or inflammatory diseases. Measurement of gd-IgA1 in serum and kidney tissue have been proposed as a potential biomarker that may help establish diagnosis and differentiate between primary and secondary forms of the disease.…”
Section: Igan and Bowel Diseasementioning
confidence: 99%
“…Intestinal inflammation with associated increased intestinal permeability and modifications to the gut microbiota, are shared pathogenic features between these two conditions. 83 Furthermore, it is unclear whether IgAN associated to IBD van be considered a primary form of IgAN as opposed to secondary IgAN as seen in liver disorders, neoplastic, or inflammatory diseases. Measurement of gd-IgA1 in serum and kidney tissue have been proposed as a potential biomarker that may help establish diagnosis and differentiate between primary and secondary forms of the disease.…”
Section: Igan and Bowel Diseasementioning
confidence: 99%
“…Moreover, enteric corticosteroid; budesonide ameliorated proteinuria in IgAN patients [ 87 , 88 ]. Based on these findings, gut–renal connection in IgAN had been proposed [ 89 , 90 , 91 , 92 ].…”
Section: Galt and Iga Nephropathymentioning
confidence: 99%
“…Immunoglobulin A nephropathy (IgAN) is the most common immune-associated primary glomerulonephritis worldwide, characterized by the deposition of IgA, specifically, galactose-deficient IgA1 (Gd-IgA1), in the glomerular mesangium ( Monteiro and Berthelot, 2021 ). Up to 40% of patients ultimately progress to end-stage kidney disease ( Selvaskandan et al., 2022 ).…”
Section: Introductionmentioning
confidence: 99%